← Back to Patent Explorer
US3723453A Expired / Lapsed US ⏱️ 0.0 years remaining

1-(beta-sulphonyloxy-ethyl)-imidazoles

Assignee: RECH ET APPLIC SCIENT ET MEDIC
•
Filing: 1970-06-17
•
Granted: 1973-03-27
•
Expires: 1990-06-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1-( Beta -Sulphonyloxy-ethyl)-imidazoles of formula WHERE R is hydrogen or lower alkyl and R1 is an alkyl radical, a cycloalkyl radical, a substituted or unsubstituted benzyl or phenyl radical; or a tetrahydrofurfuryl radical and their pharmaceutically acceptable acid addition salts show activity against a large variety of bacteria, mycetes, pathogenic moulds and protozoa and also show a good cytostatic action vitro. They are prepared by reacting the sodium salt of a corresponding free imidazole with a sulphonyloxy-ethyl halide or a corresponding 1( Beta -hydroxy-ethyl)-imidazole with a sulphonyl chloride.

Inventors

  • 👤 Asta L Dall
  • 👤 B Gradnik
  • 👤 A Pedrazzoli

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 23:53
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/54; C07D233/66; C07D233/91; C07D233/92; C07D233/94

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 21 words
A member selected from the group consisting of (a) 1-( Beta -methylsulphonyloxy)-ethyl)-2-methyl-5-nitro-imidazole and (b) a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 3 words
1-( Beta -(methylsulphonyloxy)-ethyl)-5-nitro-imidazole
Claim 3
Dependent Claim 3 words
1-( Beta -(ethylsulphonyloxy-ethyl)-2-methyl-5-nitro-imidazole.
Claim 4
Dependent Claim 3 words
1-( Beta -(n-butylsulphonyloxy)-ethyl)-2methyl-5-nitro-imidazole.
Claim 5
Dependent Claim 3 words
1-( Beta -(1''-methyl-propylsulphonyloxy)-ethyl)-2-methyl-5-nitroimidazole.
Claim 6
Dependent Claim 3 words
1-( Beta (3''-methyl-butyl-sulphonyloxy)-ethyl)-2-methyl-5nitroimidazole.
Claim 7
Dependent Claim 3 words
1-( Beta -(n-dodecylsulphonyloxy)-ethyl)-2-methyl-5nitro-imidazole.
Claim 8
Dependent Claim 3 words
1-( Beta -(cyclopentyl-sulphonyloxy)-ethyl)-2-methyl-5nitroimidazole.

References Cited (Backward Citations)

GB836854A Cited
FR3601M Cited
GB1153347A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1976-03-26 1976-09-25 1977-03-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1980-03-26 1980-09-25 1981-03-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1984-03-26 1984-09-25 1985-03-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag